NasdaqGM - Delayed Quote USD
EyePoint Pharmaceuticals, Inc. (EYPT)
8.94
+0.69
+(8.36%)
At close: June 6 at 4:00:01 PM EDT
9.00
+0.06
+(0.67%)
After hours: June 6 at 7:57:35 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 10 | 11 |
| Avg. Estimate | -0.82 | -0.77 | -2.05 | -2.79 |
| Low Estimate | -0.96 | -1.01 | -2.05 | -2.96 |
| High Estimate | -0.55 | -0.55 | -2.05 | -1.35 |
| Year Ago EPS | -0.58 | -0.54 | -2.32 | -2.05 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 13 | 13 |
| Avg. Estimate | 6.82M | 7.85M | 39.99M | 19.6M |
| Low Estimate | 6.82M | 7.85M | 29.03M | 17.85M |
| High Estimate | 13M | 13M | 66M | 57.86M |
| Year Ago Sales | 9.48M | 10.52M | 43.27M | 29.03M |
| Sales Growth (year/est) | -28.00% | -25.45% | -7.59% | -32.51% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.51 | -0.54 | -0.48 | -0.69 |
| EPS Actual | -0.58 | -0.54 | -0.64 | -0.65 |
| Difference | -0.07 | -0 | -0.16 | 0.04 |
| Surprise % | -14.45% | -0.17% | -34.32% | 5.77% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.82 | -0.77 | -2.05 | -2.96 |
| 7 Days Ago | -0.82 | -0.77 | 0 | 0 |
| 30 Days Ago | -0.72 | -0.76 | 0 | 0 |
| 60 Days Ago | -0.72 | -0.76 | 0 | 0 |
| 90 Days Ago | -0.58 | -0.61 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 2 | 1 | 2 |
| Up Last 30 Days | 1 | 3 | 3 | 3 |
| Down Last 7 Days | 3 | 1 | 1 | -- |
| Down Last 30 Days | 8 | 7 | 7 | 6 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| EYPT | -41.97% | -43.09% | 11.60% | -36.19% |
| S&P 500 | 13.12% | 2.46% | 7.54% | 13.99% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/29/2025 |
| Maintains | Mizuho: Outperform to Outperform | 5/16/2025 |
| Maintains | Chardan Capital: Buy to Buy | 5/8/2025 |
| Maintains | Chardan Capital: Buy to Buy | 3/6/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/6/2025 |
| Maintains | Chardan Capital: Buy to Buy | 2/6/2025 |
Related Tickers
OCUL Ocular Therapeutix, Inc.
9.02
+6.62%
ETNB 89bio, Inc.
10.25
+2.91%
FDMT 4D Molecular Therapeutics, Inc.
4.3500
+11.25%
AVBP ArriVent BioPharma, Inc.
23.52
+0.21%
GLUE Monte Rosa Therapeutics, Inc.
5.01
+8.44%
CLSD Clearside Biomedical, Inc.
0.7865
+1.48%
KOD Kodiak Sciences Inc.
4.2200
+7.65%
RGNX REGENXBIO Inc.
9.61
+14.95%
ADVM Adverum Biotechnologies, Inc.
2.8300
+16.94%
COGT Cogent Biosciences, Inc.
6.80
+13.52%